In this interview, Spencer King and Ajay Kirtane discuss EVOLVE Short DAPT (A Single Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated a Bioabsorbable Polymer-Based Everolimus-Eluting Stent).